Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Keith Campbell

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Journal of the American Pharmacists Association : Japha|October 6, 2009
Fate of the beta-cell in the pathophysiology of type 2 diabetesR Keith Campbell
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 20, 2002
Role of the pharmacist in diabetes managementR Keith Campbell
Clinical Therapeutics|June 14, 2011
Clarifying the role of incretin-based therapies in the treatment of type 2 diabetes mellitusR Keith Campbell
Journal of the American Pharmacists Association : Japha|October 6, 2009
Type 2 diabetes: where we are today: an overview of disease burden, current treatments, and treatment strategiesR Keith Campbell
The American Journal of Managed Care|May 8, 2012
Recommendations for improving adherence to type 2 diabetes mellitus therapy--focus on optimizing insulin-based therapyR Keith Campbell
The Annals of Pharmacotherapy|March 23, 2006
DiabetesR Keith Campbell
Diabetes Spectrum : a Publication of the American Diabetes Association|August 7, 2015
Pharmacotherapy of Diabetes: Past, Present, and Future: PrefaceR Keith Campbell
The Annals of Pharmacotherapy|December 28, 2006
Rationale for dipeptidyl peptidase 4 inhibitors: a new class of oral agents for the treatment of type 2 diabetes mellitusR Keith Campbell
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 15, 2007
Etiology and effect on outcomes of hyperglycemia in hospitalized patientsR Keith Campbell
Journal of the American Pharmacists Association : Japha|November 25, 2003
Unraveling the mysteries of syndrome X. As the number of Americans with insulin resistance grows, pharmacists can help patients prevent the onset of type 2 diabetes and cardiovascular diseaseR Keith Campbell
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Journal of the American Pharmacists Association : Japha|October 6, 2009
Fate of the beta-cell in the pathophysiology of type 2 diabetesR Keith Campbell
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 20, 2002
Role of the pharmacist in diabetes managementR Keith Campbell
Clinical Therapeutics|June 14, 2011
Clarifying the role of incretin-based therapies in the treatment of type 2 diabetes mellitusR Keith Campbell
Journal of the American Pharmacists Association : Japha|October 6, 2009
Type 2 diabetes: where we are today: an overview of disease burden, current treatments, and treatment strategiesR Keith Campbell
The American Journal of Managed Care|May 8, 2012
Recommendations for improving adherence to type 2 diabetes mellitus therapy--focus on optimizing insulin-based therapyR Keith Campbell
The Annals of Pharmacotherapy|March 23, 2006
DiabetesR Keith Campbell
Diabetes Spectrum : a Publication of the American Diabetes Association|August 7, 2015
Pharmacotherapy of Diabetes: Past, Present, and Future: PrefaceR Keith Campbell
The Annals of Pharmacotherapy|December 28, 2006
Rationale for dipeptidyl peptidase 4 inhibitors: a new class of oral agents for the treatment of type 2 diabetes mellitusR Keith Campbell
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 15, 2007
Etiology and effect on outcomes of hyperglycemia in hospitalized patientsR Keith Campbell
Journal of the American Pharmacists Association : Japha|November 25, 2003
Unraveling the mysteries of syndrome X. As the number of Americans with insulin resistance grows, pharmacists can help patients prevent the onset of type 2 diabetes and cardiovascular diseaseR Keith Campbell
Pageof 6